Interleukin-6 promoter polymorphisms and susceptibility to atrial fibrillation in Elderly Han Chinese patients with essential hypertension

Journal of Interferon and Cytokine Research

Volumn 32, Issue 11, 2012, Pages 542-547

  Li, Jing ^a   Song, Jie ^a   Jiang, Min Hui ^a   Zheng, Jin Guo ^b   Gao, Shu Ping ^c   Zhu, Jian Hua ^a   Pan, Min ^a  

^a NANTONG UNIVERSITY   (China)

^b Xinghua People's Hospital   (China)

^c Ningxia People's Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

AGED; ALLELE; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CHINESE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DISEASE PREDISPOSITION; DNA POLYMORPHISM; ESSENTIAL HYPERTENSION; FEMALE; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; GERIATRIC PATIENT; HEART ATRIUM FIBRILLATION; HEART LEFT ATRIUM; HEART LEFT VENTRICLE EJECTION FRACTION; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; SMOKING; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; ATRIAL FIBRILLATION; CASE-CONTROL STUDIES; CHINA; CHOLESTEROL; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; HYPERTENSION; INFLAMMATION; INTERLEUKIN-6; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC;

EID: 84869055396     PISSN: 10799907     EISSN: 15577465     Source Type: Journal    
DOI: 10.1089/jir.2012.0033     Document Type: Article

References (58)

1. Antonicelli R, Olivieri F, Bonafe M, Cavallone L, Spazzafumo L, Marchegiani F, Cardelli M, Recanatini A, Testarmata P, Boemi M, Parati G, Franceschi C. 2005. The interleukin-6-174 G>C promoter polymorphism is associated with a higher risk of death after an acute coronary syndrome in male elderly patients. Int J Cardiol 103:266-271. (Pubitemid 41132594)
2. Arnar DO, Thorvaldsson S, Manolio TA, Thorgeirsson G, Kristjansson K, Hakonarson H, Stefansson K. 2006. Familial aggregation of atrial fibrillation in Iceland. Eur Heart J 27: 708-712.
3. Asselbergs FW, Moore JH, van den Berg MP, Rimm EB, de Boer RA, Dullaart RP, Navis G, van GWH. 2006. A role for CETP TaqIB polymorphism in determining susceptibility to atrial fibrillation: a nested case control study. BMC Med Genet 7:39.
4. Bennermo M, Nordin M, Lundman P, Boqvist S, Held C, Samnegard A, Ericsson CG, Silveira A, Hamsten A, Nastase MM, Tornvall P. 2011. Genetic and environmental influences on the plasma interleukin-6 concentration in patients with a recent myocardial infarction: a case-control study. J Interferon Cytokine Res 31:259-264.
5. Biasucci LM, Vitelli A, Liuzzo G, Altamura S, Caligiuri G, Monaco C, Rebuzzi AG, Ciliberto G, Maseri A. 1996. Elevated levels of interleukin-6 in unstable angina. Circulation 94: 874-877. (Pubitemid 26292834)
6. Burzotta F, Iacoviello L, Di CA, Glieca F, Luciani N, Zamparelli R, Schiavello R, Donati MB, Maseri A, Possati G, Andreotti F. 2001. Relation of the - 174 G/C polymorphism of interleukin- 6 to interleukin-6 plasma levels and to length of hospitalization after surgical coronary revascularization. Am J Cardiol 88:1125-1128. (Pubitemid 33043843)
7. Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S, Van Gelder IC, Al-Attar N, Hindricks G, Prendergast B, Heidbuchel H, Alfieri O, Angelini A, Atar D, Colonna P, De Caterina R, De Sutter J, Goette A, Gorenek B, Heldal M, Hohloser SH, Kolh P, Le HJY, Ponikowski P, Rutten FH. 2010. Guidelines for the management of atrial fibrillation: the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC). Eur Heart J 31:2369-2429.
8. Cardellini M, Perego L, D'Adamo M, Marini MA, Procopio C, Hribal ML, Andreozzi F, Frontoni S, Giacomelli M, Paganelli M, Pontiroli AE, Lauro R, Folli F, Sesti G. 2005. C-174G polymorphism in the promoter of the interleukin-6 gene is associated with insulin resistance. Diabetes Care 28:2007-2012. (Pubitemid 41060976)
9. Chen F, Guo J, Gao SP, Chen C, Guo YF, Gui L, Geng HH, Ge LJ, Zhu JH, Pan M. 2011. Interleukin-6-634C >G polymorphism in hypertensive patients with and without left ventricular hypertrophy. Mol Med Rep 4:283-289.
10. Chen LY, Ballew JD, Herron KJ, Rodeheffer RJ, Olson TM. 2007. A common polymorphism in SCN5A is associated with lone atrial fibrillation. Clin Pharmacol Ther 81:35-41. (Pubitemid 46050865)
11. Chen SY, Chen CH, Huang YC, Chuang HM, Lo MM, Tsai FJ. 2010. Effect of IL-6 C-572G polymorphism on idiopathic membranous nephropathy risk in a Han Chinese population. Ren Fail 32:1172-1176.
12. Chen YH, Xu SJ, Bendahhou S, Wang XL, Wang Y, Xu WY, Jin HW, Sun H, Su XY, Zhuang QN, Yang YQ, Li YB, Liu Y, Xu HJ, Li XF, Ma N, Mou CP, Chen Z, Barhanin J, Huang W. 2003. KCNQ1 gain-of-function mutation in familial atrial fibrillation. Science 299:251-254. (Pubitemid 36125211)
13. Cherel M, Campion L, Bezieau S, Campone M, Charrier J, Gaschet J, Ricolleau G, Gouraud W, Charbonnel C, Jezequel P. 2009. Molecular screening of interleukin-6 gene promoter and influence of - 174G/C polymorphism on breast cancer. Cytokine 47:214-223.
14. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr., Jones DW, Materson BJ, Oparil S, Wright JT, Jr., Roccella EJ. 2003. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 289: 2560-2572. (Pubitemid 37430158)
15. Dernellis J, Panaretou M. 2001. C-reactive protein and paroxysmal atrial fibrillation: evidence of the implication of an inflammatory process in paroxysmal atrial fibrillation. Acta Cardiol 56:375-380.
16. Ellinor PT, Shin JT, Moore RK, Yoerger DM, MacRae CA. 2003. Locus for atrial fibrillation maps to chromosome 6q14-16. Circulation 107:2880-2883. (Pubitemid 36736626)
17. Fan WH, Liu DL, Xiao LM, Xie CJ, Sun SY, Zhang JC. 2011. Coronary heart disease and chronic periodontitis: is polymorphism of interleukin-6 gene the common risk factor in a Chinese population. Oral Dis 17:270-276.
18. Fox CS, Parise H, D'Agostino RB, Sr., Lloyd-Jones DM, Vasan RS, Wang TJ, Levy D, Wolf PA, Benjamin EJ. 2004. Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring. JAMA 291:2851-2855. (Pubitemid 38747806)
19. Frustaci A, Chimenti C, Bellocci F, Morgante E, Russo MA, Maseri A. 1997. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation 96:1180-1184. (Pubitemid 27344221)
20. Gai X, Zhang Z, Liang Y, Chen Z, Yang X, Hou J, Lan X, Zheng W, Hou J, Huang M. 2010. MMP-2 and TIMP-2 gene polymorphisms and susceptibility to atrial fibrillation in Chinese Han patients with hypertensive heart disease. Clin Chim Acta 411:9-10.
21. Gao SP, Deng XT, Ge LJ, Luan H, Zheng JG, Chen C, Jiang MH, Pan M. 2011a. Is inflammation linked to thrombogenesis in atrial fibrillation. Int J Cardiol 149:260-261.
22. Gao SP, Pan M, Chen C, Ge LJ, Jiang MH, Luan H, Zheng JG, Deng XT, Pan HY, Zhu JH. 2011b. The G to A polymorphism at - 597 of the interleukin-6 gene is extremely rare in southern Han Chinese. Cytokine 55:1-3.
23. Gedikli O, Dogan A, Altuntas I, Altinbas A, Ozaydin M, Akturk O, Acar G. 2007. Inflammatory markers according to types of atrial fibrillation. Int J Cardiol 120:193-197. (Pubitemid 47042252)
24. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, Singer DE. 2001. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 285:2370-2375. (Pubitemid 32424106)
25. Gudbjartsson DF, Arnar DO, Helgadottir A, Gretarsdottir S, Holm H, Sigurdsson A, Jonasdottir A, Baker A, Thorleifsson G, Kristjansson K, Palsson A, Blondal T, Sulem P, Backman VM, Hardarson GA, Palsdottir E, Helgason A, Sigurjonsdottir R, Sverrisson JT, Kostulas K, Ng MC, Baum L, So WY, Wong KS, Chan JC, Furie KL, Greenberg SM, Sale M, Kelly P, MacRae CA, Smith EE, Rosand J, Hillert J, Ma RC, Ellinor PT, Thorgeirsson G, Gulcher JR, Kong A, Thorsteinsdottir U, Stefansson K. 2007. Variants conferring risk of atrial fibrillation on chromosome 4q25. Nature 448:353-357. (Pubitemid 47080348)
26. Hamid YH, Rose CS, Urhammer SA, Glumer C, Nolsoe R, Kristiansen OP, Mandrup-Poulsen T, Borch-Johnsen K, Jorgensen T, Hansen T, Pedersen O. 2005. Variations of the interleukin-6 promoter are associated with features of the metabolic syndrome in Caucasian Danes. Diabetologia 48: 251-260. (Pubitemid 40543296)
27. Humphries SE, Luong LA, Ogg MS, Hawe E, Miller GJ. 2001. The interleukin-6-174 G/C promoter polymorphism is associated with risk of coronary heart disease and systolic blood pressure in healthy men. Eur Heart J 22:2243-2252. (Pubitemid 34000979)
28. Jang Y, Kim OY, Hyun YJ, Chae JS, Koh SJ, Heo YM, Choi D, Shin DJ, Huttner K, Lee JH. 2008. Interleukin-6-572C >G polymorphism-association with inflammatory variables in Korean men with coronary artery disease. Transl Res 151: 154-161. (Pubitemid 351221437)
29. Kamiyama N. 1998. Expression of cell adhesion molecules and the appearance of adherent leukocytes on the left atrial endothelium with atrial fibrillation: rabbit experimental model. Jpn Circ J 62:837-843.
30. Kannel WB, Abbott RD, Savage DD, McNamara PM. 1982. Epidemiologic features of chronic atrial fibrillation: the Framingham study. N Engl J Med 306:1018-1022. (Pubitemid 12155370)
31. Kitamura A, Hasegawa G, Obayashi H, Kamiuchi K, Ishii M, Yano M, Tanaka T, Yamaguchi M, Shigeta H, Ogata M, Nakamura N, Yoshikawa T. 2002. Interleukin-6 polymorphism (- 634C/G) in the promotor region and the progression of diabetic nephropathy in type 2 diabetes. Diabet Med 19:1000- 1005. (Pubitemid 35471968)
32. Koh SJ, Jang Y, Hyun YJ, Park JY, Song YD, Shin KK, Chae JS, Kim BK, Ordovas JM, Lee JH. 2009. Interleukin-6 (IL-6) - 572C - >G promoter polymorphism is associated with type 2 diabetes risk in Koreans. Clin Endocrinol (Oxf) 70:238-244.
33. Krahn AD, Manfreda J, Tate RB, Mathewson FA, Cuddy TE. 1995. The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. AmJ Med 98:476-484.
34. Kruttgen A, Rose-John S. 2012. Interleukin-6 in sepsis and capillary leakage syndrome. J Interferon Cytokine Res 32:60-65.
35. Lip GY, Patel JV, Hughes E, Hart RG. 2007. High-sensitivity C-reactive protein and soluble CD40 ligand as indices of inflammation and platelet activation in 880 patients with nonvalvular atrial fibrillation: relationship to stroke risk factors, stroke risk stratification schema, and prognosis. Stroke 38:1229-1237. (Pubitemid 351664238)
36. Lubitz SA, Sinner MF, Lunetta KL, Makino S, Pfeufer A, Rahman R, Veltman CE, Barnard J, Bis JC, Danik SP, Sonni A, Shea MA, Del MF, Perz S, Muller M, Peters A, Greenberg SM, Furie KL, van NC, Boerwinkle E, Stricker BH, Witteman J, Smith JD, Chung MK, Heckbert SR, Benjamin EJ, Rosand J, Arking DE, Alonso A, Kaab S, Ellinor PT. 2010. Independent susceptibility markers for atrial fibrillation on chromosome 4q25. Circulation 122:976-984.
37. Marcus GM, Whooley MA, Glidden DV, Pawlikowska L, Zaroff JG, Olgin JE. 2008. Interleukin-6 and atrial fibrillation in patients with coronary artery disease: data from the Heart and Soul Study. Am Heart J 155:303-309.
38. Nakamura Y, Nakamura K, Fukushima-Kusano K, Ohta K, Matsubara H, Hamuro T, Yutani C, Ohe T. 2003. Tissue factorexpression in atrial endothelia associated with nonvalvular atrial fibrillation: possible involvement in intracardiac thrombogenesis. Thromb Res 111:137-142. (Pubitemid 37540411)
39. Olson TM, Michels VV, Ballew JD, Reyna SP, Karst ML, Herron KJ, Horton SC, Rodeheffer RJ, Anderson JL. 2005. Sodium channel mutations and susceptibility to heart failure and atrial fibrillation. JAMA 293:447-454.
40. Paik JK, Kim OY, Koh SJ, Jang Y, Chae JS, Kim JY, Kim HJ, Hyun YJ, Cho JR, Lee JH. 2007. Additive effect of interleukin-6 and C-reactive protein (CRP) single nucleotide polymorphism on serum CRP concentration and other cardiovascular risk factors. Clin Chim Acta 380:68-74. (Pubitemid 46498024)
41. Pan M, Gao SP, Jiang MH, Guo J, Zheng JG, Zhu JH. 2011. Interleukin 6 promoter polymorphisms in normal Han Chinese population: frequencies and effects on inflammatory markers. J Investig Med 59:272-276.
42. Pan M, Jiang MH, Wei MF, Liu ZH, Jiang WP, Geng HH, Cui ZC, Zhang DL, Zhu JH. 2009. Association of angiotensinconverting enzyme gene 2350G >A polymorphism with myocardial infarction in a Chinese population. Clin Appl Thromb Hemost 15:435-442.
43. Pan M, Zhu JH, Jiang WP, Liu ZH, Li HM, Yu XH, Yang XJ. 2006. Inflammation: a possible pathogenic link to atrial fibrillation.Med Hypotheses 67:1305-1307. (Pubitemid 44442636)
44. Pantsulaia I, Trofimov S, Kobyliansky E, Livshits G. 2002. Genetic and environmental influences on IL-6 and TNF-alpha plasma levels in apparently healthy general population. Cytokine 19:138-146. (Pubitemid 35216194)
45. Psychari SN, Apostolou TS, Sinos L, Hamodraka E, Liakos G, Kremastinos DT. 2005. Relation of elevated C-reactive protein and interleukin-6 levels to left atrial size and duration of episodes in patients with atrial fibrillation. Am J Cardiol 95: 764-767. (Pubitemid 40340139)
46. Ravishankaran P, Shah AM, Bhat R. 2011. Correlation of interleukin- 6, serum lactate, and C-reactive protein to inflammation, complication, and outcome during the surgical course of patients with acute abdomen. J Interferon Cytokine Res 31:685-690.
47. Saijo Y, Yoshioka E, Fukui T, Kawaharada M, Sata F, Sato H, Kishi R. 2007. Effects of the interaction between interleukin-6- 634C/G polymorphism and smoking on serum C-reactive protein concentrations. Hypertens Res 30:593-599. (Pubitemid 47278316)
48. Schulte F, Schnulle P, Bugert P, Kluter H, Muller-Steinhardt M. 2011. The interleukin-6 promoter (-597/-572/-174)genotype does not affect interleukin-6 production in hemodialysis patients. J Interferon Cytokine Res 31:639-642.
49. Shibata N, Ohnuma T, Takahashi T, Baba H, Ishizuka T, Ohtsuka M, Ueki A, Nagao M, Arai H. 2002. Effect of IL-6 polymorphism on risk of Alzheimer disease: genotype-phenotype association study in Japanese cases. Am J Med Genet 114: 436-439. (Pubitemid 34525242)
50. Shin KK, Jang Y, Koh SJ, Chae JS, Kim OY, Park S, Choi D, Shin DJ, Kim HJ, Lee JH. 2007. Influence of the IL-6-572C >G polymorphism on inflammatory markers according to cigarette smoking in Korean healthy men. Cytokine 39:116-122. (Pubitemid 47513835)
51. Siu CW, Lau CP, Tse HF. 2003. Prevention of atrial fibrillation recurrence by statin therapy in patients with lone atrial fibrillation after successful cardioversion. Am J Cardiol 92: 1343-1345.
52. Smith AJ, D'Aiuto F, Palmen J, Cooper JA, Samuel J, Thompson S, Sanders J, Donos N, Nibali L, Brull D, Woo P, Humphries SE. 2008. Association of serum interleukin-6 concentration with a functional IL6-6331T >C polymorphism. Clin Chem 54:841-850. (Pubitemid 351671601)
53. Terry CF, Loukaci V, Green FR. 2000. Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation. J Biol Chem 275:18138-18144. (Pubitemid 30414764)
54. Tsai CT, Lai LP, Lin JL, Chiang FT, Hwang JJ, Ritchie MD, Moore JH, Hsu KL, Tseng CD, Liau CS, Tseng YZ. 2004. Renin-angiotensin system gene polymorphisms and atrial fibrillation. Circulation 109:1640-1646. (Pubitemid 38451721)
55. Verdecchia P, Reboldi G, Gattobigio R, Bentivoglio M, Borgioni C, Angeli F, Carluccio E, Sardone MG, Porcellati C. 2003. Atrial fibrillation in hypertension: predictors and outcome. Hypertension 41:218-223. (Pubitemid 36204892)
56. Verheule S, Wilson E, 4th ET, Shanbhag S, Golden C, Olgin J. 2003. Alterations in atrial electrophysiology and tissue structure in a canine model of chronic atrial dilatation due to mitral regurgitation. Circulation 107:2615-2622. (Pubitemid 36628945)
57. Wang QS, Li YG, Chen XD, Yu JF, Wang J, Sun J, Lu SB, Jin L, Wang XF. 2010. Angiotensinogen polymorphisms and acquired atrial fibrillation in Chinese. J Electrocardiol 43:373-377.
58. Zhang X, Ma L, Peng F, Wu Y, Chen Y, Yu L, Lei Z, Zhang C. 2011. The endothelial dysfunction in patients with type 2 diabetes mellitus is associated with IL-6 gene promoter polymorphism in Chinese population. Endocrine 40:124-129.